Nachrichten zur Moderna Aktie

Moderna Teams With IBM to Explore AI, Quantum Computing in Vaccine Development

Moderna Teams With IBM to Explore AI, Quantum Computing in Vaccine Development...…

Moderna, Inc.: Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science

Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicinesAgreement with…

Is Moderna About to Face the Same Challenge as Other Biotechs?

Investors have gotten used to Modernas rapid vaccine development....…

Moderna (MRNA) Gains As Market Dips: What You Should Know

In the latest trading session, Moderna (MRNA) closed at $142.82, marking a +0.13% move from the previous day....…

Moderna Stock: Bear vs. Bull

Moderna shares have delivered big for early investors....…

FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines

NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration said it has amended the emergency use authorizations or…

FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines

The U.S. Food and Drug Administration said it has amended the emergency use authorizations or EUAs of COVID-19 bivalent mRNA…

Moderna Inc. stock outperforms competitors despite losses on the day

Moderna Inc. stock outperforms competitors despite losses on the day...…

Tuesday’s Top Analyst Upgrades and Downgrades: Boston Scientific, GM, JPMorgan, Match, Moderna, Snap, Uber, Wells Fargo and More

Tuesdays top analyst upgrades and downgrades included Agilon Health, Boston Scientific, General Motors, JPMorgan Chase, Match, Moderna, Okta, Palo Alto…

FDA withdraws authorization for older COVID vaccines by Moderna, Pfizer

...April 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday......…

Why did Moderna stock drop today? mRNA cancer therapy data

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna Inc. stock underperforms Monday when compared to competitors

Moderna Inc. stock underperforms Monday when compared to competitors...…

Why Moderna Stock Plunged Today

Mildly positive results from a phase 2b cancer trial fell short of more hopeful investors expectations....…

BioNTech-Konkurrent Moderna: Aktie erneut deutlich unter Druck – Studiendaten im Fokus

Die Aktie des US-Biotechunternehmens Moderna steht zu Wochenbeginn erneut kräftig unter Druck. Rund eine Stunde vor dem US-Handelsende notiert das…

Stocks making the biggest moves midday: Alphabet, Charles Schwab, State Street, Moderna and more

These are the stocks posting the largest moves in midday trading....…

Blitz-Update: Dow & Co uneinheitlich, Boeing, Enphase Energy und Prometheus Biosciences stark, Alphabet, State Street und Moderna deutlich unter Druck

Die US-Aktienmärkte haben sich zum Auftakt der neuen Börsenwoche ohne klare Richtung präsentiert. Während sich die Standardwerte am Montag an…

Moderna shares fall despite promising data from cancer vaccine trial

Modernas mRNA vaccine, when combined with Mercks blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer....…

Moderna Cancer-Therapy Sees More Upbeat Data

New data bolster the case for Moderna’s experimental cancer treatment, but the path to turning it into a marketable product…

Moderna, Roblox, State Street And Other Big Stocks Moving Lower On Monday

U.S. stocks traded mixed, with the Dow Jones dropping over 25 points on Monday. Here are some big stocks recording…

Biotechnologie: mRNA-Impfstoff senkt Hautkrebs-Rückfallrisiko deutlich

Die Daten zum Wirkstoff von Moderna stärken die Zuversicht für einen erfolgreichen Einsatz von mRNA-Technologie gegen Krebs. Doch die Forscher…

Moderna: Geben neue Daten der Aktie einen Schub?

Moderna (WKN: A2N9D9), das in Zusammenarbeit mit Merck an Krebsspritzen gegen Hauterkrankungen arbeitet, hat nun die Ergebnisse seiner zweiten klinischen…

This Prediction May Completely Change Your Opinion of Moderna

This stock may reward those who buy and hold for the long term....…

Prometheus, Merck, Moderna, Charles Schwab, and More Stock Market Movers

Merck agrees to buy Prometheus Biosciences for about $10.8 billion, and Charles Schwab reports quarterly earnings on Monday, kicking off…

Moderna, Inc.: Moderna and Merck Announce mRNA-4157, an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA , Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Comple

mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in…

Die Verlierer des Tesla-Effekts und lukrative Nebenwerte-ETFs

In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Daniel Eckert und Nando Sommerfeldt über die Image-Schlappe von Lilium,…

Moderna, Merck post detailed Phase 2 data for mRNA cancer shot in melanoma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna, Merck combo cancer-vaccine treatment shows ‘significant’ promise

A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing…

UPDATE 1-Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return

... Steenhuysen and Michael Erman April 16 (Reuters) - An experimental mRNA cancer......…

Moderna Shows Progress Toward Cancer Vaccines

An mRNA shot helped prevent relapse in high-risk melanoma patients....…

Merck-Moderna Vaccine Helps Keytruda Keep Melanoma Patients ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna, Inc.: Moderna and Merck Announce mRNA-4157 , an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA , Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Compl

mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in…

Catalent warns of production issues, finishes day as worst S&P 500 performer

CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on Catalent and Moderna....…

Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 6.267.336$

Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-12...…

Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 6.430.340$

Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-13...…

Dow & Co grenzen Verluste ein: JPMorgan, Alphabet und Nvidia unter den Top-Werten, Boeing, UnitedHealth, Moderna, Netflix und Rivian geben deutlich nach – der Tag an der Wall Street

Kursgewinne im US-Finanzsektor nach starken Geschäftszahlen von Banken haben am Freitag die US-Aktienindizes nicht vor Verlusten geschützt. Der Grund waren…

Moderna Inc. stock underperforms Friday when compared to competitors

Moderna Inc. stock underperforms Friday when compared to competitors...…

Moderna: Vaccines Day hinterlässt mehr Fragen als Antworten - Aktienanalyse

Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse von BofA Securities: Die Analysten von BofA Securities stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN:…

Moderna Inc. stock outperforms competitors on strong trading day

Moderna Inc. stock outperforms competitors on strong trading day...…

Biotech Stock Roundup: MRNA Provides Update, KALA, IFRX Surge on Regulatory News

Regulatory and pipeline updates from Moderna (MRNA) and KALA are the key highlights for the biotech sector....…

Can Pfizer Beat GSK and Moderna in This $10 Billion Market?

Theres such a big need in preventing RSV that multiple companies should be big winners....…

Moderna (MRNA) Gains As Market Dips: What You Should Know

In the latest trading session, Moderna (MRNA) closed at $155.56, marking a +0.2% move from the previous day....…

Moderna (MRNA) Posts 2027 Biz View, Down 3% on Flu Jab Setback

Moderna (MRNA) expects $8-$15 billion in product revenues from the respiratory vaccine by 2027. Its first influenza vaccine candidate failed…

US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma

read more...…

Moderna eyes local COVID vaccines for Japan, other countries

Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chief Executive Officer verkauft Aktien von MRNA im Wert von 6.298.950$

Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-06...…

Insiderhandel: Chief Executive Officer verkauft Aktien von MRNA im Wert von 6.185.585$

Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-05...…

22-Year-Old National Guard Soldier Suffers Two Heart Attacks, Neurological Issues After Moderna Vax

22-Year-Old National Guard Soldier Suffers Two Heart Attacks, Neurological Issues After Moderna Vax …

Moderna Inc. stock falls Tuesday, underperforms market

Moderna Inc. stock falls Tuesday, underperforms market...…

Dow im Plus, Tech-Werte im Minus, US-Leitzins im Fokus, Caterpillar, Nike, Carmax, Lucid und Tesla top, Microsoft und Moderna schwach – der Tag an der Wall Street

Die US-Aktienmärkte haben sich am Dienstag in unterschiedliche Richtungen bewegt. Insgesamt dominierte im späten Handel die Vorsicht. So dämmte der…

Moderna, TSR fall; CarMax, Coinbase rise

Stocks that traded heavily or had substantial price changes Tuesday: Moderna, TSR fall; CarMax, Coinbase rise...…